Moderna, Inc. Investment Income, Interest
Moderna, Inc. (MRNA) reported Investment Income, Interest of $67.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-07-31
- Moderna, Inc. investment income, interest for the quarter ending 2026-06-30 was $67.00M, a 17.28% decline year-over-year.
- Moderna, Inc. investment income, interest for the quarter ending 2026-03-31 was $72.00M, a 20.00% decline year-over-year.
- Moderna, Inc. investment income, interest for the quarter ending 2025-12-31 was $70.00M, a 23.08% decline year-over-year.
- Moderna, Inc. investment income, interest for the quarter ending 2025-09-30 was $73.00M, a 29.13% decline year-over-year.
- Moderna, Inc. investment income, interest for fiscal 2025 was $314.00M, a 26.12% decline from fiscal 2024.
- Moderna, Inc. investment income, interest for fiscal 2024 was $425.00M, a 0.95% increase from fiscal 2023.
- Moderna, Inc. investment income, interest for fiscal 2023 was $421.00M, a 110.50% increase from fiscal 2022.
- Moderna, Inc. investment income, interest for fiscal 2022 was $200.00M, a 1011.11% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 3 month as first filed | Investment Income, Interest 6 month | Investment Income, Interest 6 month as first filed | Investment Income, Interest 9 month | Investment Income, Interest 9 month as first filed | Investment Income, Interest 12 month | Investment Income, Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $67.00M 10-Q · filed 2026-07-31 | $139.00M 10-Q · filed 2026-07-31 | $209.00M derived: sum of 3 quarters · filed 2026-07-31 | $282.00M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2026-03-31 | $72.00M 10-Q · filed 2026-05-01 | $142.00M derived: sum of 2 quarters · filed 2026-05-01 | $215.00M derived: sum of 3 quarters · filed 2026-05-01 | $296.00M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2025-12-31 | $70.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $143.00M derived: sum of 2 quarters · filed 2026-02-20 | $224.00M derived: sum of 3 quarters · filed 2026-07-31 | $314.00M 10-K · filed 2026-02-20 | ||||
| 2025-09-30 | $73.00M 10-Q · filed 2025-11-06 | $154.00M derived: sum of 2 quarters · filed 2026-07-31 | $244.00M 10-Q · filed 2025-11-06 | $335.00M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2025-06-30 | $81.00M 10-Q · filed 2026-07-31 | $171.00M 10-Q · filed 2026-07-31 | $262.00M derived: sum of 3 quarters · filed 2026-07-31 | $365.00M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2025-03-31 | $90.00M 10-Q · filed 2026-05-01 | $181.00M derived: sum of 2 quarters · filed 2026-05-01 | $284.00M derived: sum of 3 quarters · filed 2026-05-01 | $395.00M derived: sum of 4 quarters · filed 2026-05-01 | ||||
| 2024-12-31 | $91.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $194.00M derived: sum of 2 quarters · filed 2026-02-20 | $305.00M derived: sum of 3 quarters · filed 2026-02-20 | $425.00M 10-K · filed 2026-02-20 | ||||
| 2024-09-30 | $103.00M 10-Q · filed 2025-11-06 | $214.00M derived: sum of 2 quarters · filed 2025-11-06 | $334.00M 10-Q · filed 2025-11-06 | $437.00M derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2024-06-30 | $111.00M 10-Q · filed 2025-08-01 | $231.00M 10-Q · filed 2025-08-01 | $334.00M derived: sum of 3 quarters · filed 2026-02-20 | $439.00M derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2024-03-31 | $120.00M 10-Q · filed 2025-05-01 | $223.00M derived: sum of 2 quarters · filed 2026-02-20 | $328.00M derived: sum of 3 quarters · filed 2026-02-20 | $432.00M derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2023-12-31 | $103.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $208.00M derived: sum of 2 quarters · filed 2026-02-20 | $312.00M derived: sum of 3 quarters · filed 2026-02-20 | $421.00M 10-K · filed 2026-02-20 | ||||
| 2023-09-30 | $105.00M 10-Q · filed 2024-11-07 | $209.00M derived: sum of 2 quarters · filed 2024-11-07 | $318.00M 10-Q · filed 2024-11-07 | $405.00M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-06-30 | $104.00M 10-Q · filed 2024-08-01 | $213.00M 10-Q · filed 2024-08-01 | $300.00M derived: sum of 3 quarters · filed 2025-02-21 | $358.00M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-03-31 | $109.00M 10-Q · filed 2024-05-02 | $196.00M derived: sum of 2 quarters · filed 2025-02-21 | $254.00M derived: sum of 3 quarters · filed 2025-02-21 | $294.00M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2022-12-31 | $87.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $145.00M derived: sum of 2 quarters · filed 2025-02-21 | $185.00M derived: sum of 3 quarters · filed 2025-02-21 | $200.00M 10-K · filed 2025-02-21 | ||||
| 2022-09-30 | $58.00M 10-Q · filed 2023-11-03 | $98.00M derived: sum of 2 quarters · filed 2023-11-03 | $113.00M 10-Q · filed 2023-11-03 | $120.00M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-06-30 | $40.00M 10-Q · filed 2023-08-03 | $55.00M 10-Q · filed 2023-08-03 | $62.00M derived: sum of 3 quarters · filed 2024-02-23 | $66.00M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-03-31 | $15.00M 10-Q · filed 2023-05-04 | $22.00M derived: sum of 2 quarters · filed 2024-02-23 | $26.00M derived: sum of 3 quarters · filed 2024-02-23 | $29.00M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2021-12-31 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $11.00M derived: sum of 2 quarters · filed 2024-02-23 | $14.00M derived: sum of 3 quarters · filed 2024-02-23 | $18.00M 10-K · filed 2024-02-23 | ||||
| 2021-09-30 | $4.00M 10-Q · filed 2022-11-03 | $7.00M derived: sum of 2 quarters · filed 2022-11-03 | $11.00M 10-Q · filed 2022-11-03 | $15.00M derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2021-06-30 | $3.00M 10-Q · filed 2022-08-03 | $7.00M 10-Q · filed 2022-08-03 | $11.00M derived: sum of 3 quarters · filed 2023-02-24 | $17.00M derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2021-03-31 | $4.00M 10-Q · filed 2022-05-04 | $8.00M derived: sum of 2 quarters · filed 2023-02-24 | $14.00M derived: sum of 3 quarters · filed 2023-02-24 | $21.00M derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2020-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $10.00M derived: sum of 2 quarters · filed 2023-02-24 | $17.00M derived: sum of 3 quarters · filed 2023-02-24 | $25.00M 10-K · filed 2023-02-24 | $24.71M 10-K · filed 2021-02-26 | |||
| 2020-09-30 | $6.00M 10-Q · filed 2021-11-04 | $5.57M 10-Q · filed 2020-10-30 | $13.00M derived: sum of 2 quarters · filed 2021-11-04 | $21.00M 10-Q · filed 2021-11-04 | $20.52M 10-Q · filed 2020-10-30 | $29.45M derived: sum of 4 quarters · filed 2022-02-25 | ||
| 2020-06-30 | $7.00M 10-Q · filed 2021-08-05 | $7.09M 10-Q · filed 2020-08-06 | $15.00M 10-Q · filed 2021-08-05 | $14.94M 10-Q · filed 2020-08-06 | $23.45M derived: sum of 3 quarters · filed 2022-02-25 | $32.71M derived: sum of 4 quarters · filed 2022-02-25 | ||
| 2020-03-31 | $8.00M 10-Q · filed 2021-05-06 | $7.85M 10-Q · filed 2020-05-07 | $16.45M derived: sum of 2 quarters · filed 2022-02-25 | $25.71M derived: sum of 3 quarters · filed 2022-02-25 | $36.03M derived: sum of 4 quarters · filed 2022-02-25 | |||
| 2019-12-31 | $8.45M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $17.71M derived: sum of 2 quarters · filed 2022-02-25 | $28.03M derived: sum of 3 quarters · filed 2022-02-25 | $39.00M 10-K · filed 2022-02-25 | $38.53M 10-K · filed 2020-02-27 | |||
| 2019-09-30 | $9.25M 10-Q · filed 2020-10-30 | $19.57M derived: sum of 2 quarters · filed 2020-10-30 | $30.55M 10-Q · filed 2020-10-30 | $39.44M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-06-30 | $10.32M 10-Q · filed 2020-08-06 | $21.29M 10-Q · filed 2020-08-06 | $30.19M derived: sum of 3 quarters · filed 2021-02-26 | $36.71M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-03-31 | $10.97M 10-Q · filed 2020-05-07 | $19.87M derived: sum of 2 quarters · filed 2021-02-26 | $26.39M derived: sum of 3 quarters · filed 2021-02-26 | $32.79M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2018-12-31 | $8.89M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $15.41M derived: sum of 2 quarters · filed 2021-02-26 | $21.81M derived: sum of 3 quarters · filed 2021-02-26 | $27.02M 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | $6.52M 10-Q · filed 2019-11-06 | $12.92M derived: sum of 2 quarters · filed 2019-11-06 | $18.13M 10-Q · filed 2019-11-06 | |||||
| 2018-06-30 | $6.40M 10-Q · filed 2019-08-08 | $11.61M 10-Q · filed 2019-08-08 | ||||||
| 2018-03-31 | $5.21M 10-Q · filed 2019-05-09 | |||||||
| 2017-12-31 | $15.23M 10-K · filed 2020-02-27 | |||||||
| 2016-12-31 | $11.31M 10-K · filed 2019-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |